Biomarkers for Endometriosis
ConditionEndometriosis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-45
SponsorTrio Fertility
About this trial
Endometriosis is a condition in which tissue similar to the lining of the uterus grows outside the uterus, often causing pain and infertility. Currently, endometriosis can only be definitively diagnosed through invasive procedures like laparoscopy and biopsy.
The purpose of this study is to investigate whether the proteins Synuclein Gamma (SNCG) and B-Cell Lymphoma 6 (BCL6), measurable in blood and menstrual fluid, can serve as non-invasive biomarkers to diagnose or monitor endometriosis.
Eligibility criteria
Qualifiers
Women of reproductive age group (18Y-45Y).
Women with active endometriosis diagnosed by ultrasound/MRI/laparoscopy.
Disqualifiers
Women <18Y and >45Y.
Women with endometriosis during stimulation with gonadotropins.
Current or prior history of uterine, ovarian, colon, pancreatic, breast or any other type of cancer.
Any prior history of chronic illness.
Trial design
Treatments tested in this trial
- SNCG Protein
- BCL-6 Protein
Treatment groups
100 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov